Most cancers sufferers experiencing ache regardless of different ache medicines could also be eligible to take part. The purpose of the trial is to evaluate the impact of hashish oil in relieving their signs and to achieve data on the very best oral dosing routine. Sufferers will obtain an oil combining THC and CBD.
“Sufferers with most cancers usually endure from important ache and we all know that whereas managing the ache with narcotics is commonly needed, it’s also fraught with points,” stated Dr. Marissa Slaven. “Anecdotally, most cancers sufferers have been telling us that hashish merchandise assist their ache. Due to MedReleaf’s dedication to advancing medical science we’ll now be capable to begin gathering the info wanted to assist our sufferers dwell higher.”
“Collaborating with the Ontario Oncology Group underneath the route of Dr. Levine and its associates speaks to MedReleaf’s basis as an R&D pushed firm,” stated Neil Closner, CEO MedReleaf. “We’re thrilled to have the chance to be concerned on this essential most cancers trial which has the potential to positively affect the lives of most cancers sufferers whereas advancing our understanding of the therapeutic advantages of medical hashish and validating new therapy choices for sufferers.”
OCOG is an instructional trials group based mostly within the Escarpment Most cancers Analysis Institute, a joint analysis institute of Hamilton Well being Sciences and McMaster College. OCOG works with networks of investigators to design and conduct most cancers medical trials provincially, nationally, and past. OCOG was established in 1982 and since then over 12,000 sufferers have been entered in OCOG research. The outcomes of which have impacted on medical care.
About MedReleaf Corp.
Canada’s most awarded licensed producer, MedReleaf is an R&D-driven firm devoted to innovation, operational excellence and the manufacturing of trade main, top-quality hashish. Sourced from all over the world and thoroughly cultivated in one in every of two state-of-the-art ICH-GMP and ISO 9001 licensed services in Ontario, with a 3rd facility at the moment in improvement, a full vary of premium MedReleaf merchandise are delivered to the worldwide medical market. We serve the therapeutic wants of sufferers looking for protected, constant and efficient medical hashish and supply a compelling product providing for the adult-use leisure market.